Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Rezolute, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +1 vs. Q4 2023
- Shares held
- 27.0M
- −1.91M (−6.6%) vs. Q4 2023
- Total value
- $69.0M
- +$40.2M (+139.9%) vs. Q4 2023
- New holders
- 8
- 9 more added
- Sold out
- 7
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RZLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $450.3M |
| Q1 2026 | 125 | $263.2M |
| Q4 2025 | 122 | $213.4M |
| Q3 2025 | 116 | $817.1M |
| Q2 2025 | 92 | $347.5M |
| Q1 2025 | 77 | $130.6M |
| Q4 2024 | 71 | $211.7M |
| Q3 2024 | 59 | $186.9M |
| Q2 2024 | 52 | $170.0M |
| Q1 2024 | 33 | $69.0M |
| Q4 2023 | 32 | $28.7M |
| Q3 2023 | 30 | $31.5M |
| Q2 2023 | 29 | $48.0M |
| Q1 2023 | 32 | $46.5M |
| Q4 2022 | 34 | $50.6M |
| Q3 2022 | 33 | $67.0M |
| Q2 2022 | 35 | $79.2M |
| Q1 2022 | 21 | $24.0M |
| Q4 2021 | 23 | $36.0M |
| Q3 2021 | 14 | $17.6M |
| Q2 2021 | 12 | $31.6M |
| Q1 2021 | 11 | $17.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Rezolute, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 10,154,327 | $25.9M | 0.06% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 3,022,947 | $7.71M | 0.76% | +1,485,240+96.6% | Added |
| Vivo Capital, LLC | 2,797,704 | $7.13M | 0.56% | −445,138−13.7% | Reduced |
| Affinity Asset Advisors, LLC | 1,600,000 | $4.08M | 0.66% | +1,600,000 | New |
| Vanguard Group Inc | 1,553,352 | $3.96M | 0.00% | +145,700+10.4% | Added |
| Blackstone Group Inc. | 1,537,684 | $3.92M | 0.02% | 00.0% | Unchanged |
| Caxton Corp | 1,318,967 | $3.36M | 19.16% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 996,710 | $2.54M | 0.41% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 631,690 | $1.61M | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 626,259 | $1.60M | 0.05% | +25,000+4.2% | Added |
| Velan Capital Investment Management LP | 400,000 | $1.02M | 0.55% | +400,000 | New |
| Citadel Advisors LLC | 398,423 | $1.02M | 0.00% | +51,874+15.0% | Added |
| BlackRock Inc. | 354,916 | $905.0K | 0.00% | +92,795+35.4% | Added |
| Geode Capital Management, LLC | 337,190 | $860.0K | 0.00% | +74,541+28.4% | Added |
| Renaissance Technologies LLC | 330,081 | $842.0K | 0.00% | +278,675+542.1% | Added |
| Rosalind Advisors, Inc. | 200,000 | $510.0K | 0.48% | +200,000 | New |
| BVF Inc | 190,815 | $486.6K | 0.01% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 151,985 | $387.6K | 0.11% | −5,100−3.2% | Reduced |
| Stonepine Capital Management, LLC | 121,479 | $309.8K | 0.25% | −2,647,177−95.6% | Reduced |
| Acadian Asset Management LLC | 90,346 | $229.0K | 0.00% | +90,346 | New |
| Northern Trust Corp | 67,226 | $171.4K | 0.00% | −16,760−20.0% | Reduced |
| State Street Corp | 59,572 | $151.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 20,914 | $53.3K | 0.00% | +2,695+14.8% | Added |
| Virtu Financial LLC | 14,410 | $37.0K | 0.00% | +14,410 | New |
| Charles Schwab Investment Management Inc | 13,757 | $35.1K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 12,000 | $30.6K | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 10,000 | $29.7K | 0.00% | +10,000 | New |
| Cubist Systematic Strategies, LLC | 11,640 | $29.7K | 0.00% | +11,640 | New |
| XTX Topco Ltd | 11,011 | $28.1K | 0.00% | +11,011 | New |
| Tower Research Capital LLC (TRC) | 4,886 | $12.5K | 0.00% | −6,449−56.9% | Reduced |
| Morgan Stanley | 2,071 | $5.28K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 257 | $655 | 0.00% | +22+9.4% | Added |
| Qube Research & Technologies Ltd | 2 | $5 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 0 | $0 | 0.00% | −2,680,978−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −356,978−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −217,902−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −26,988−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −340−100.0% | Sold out |